HealthInvest Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

HealthInvest Partners’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-710,000	Closed	-$8.93M	–	14
2022 Q1	$8.93M	Sell	710,000 -20,000	-3%	-$229K	14.22%	2
2021 Q4	$8.51M	Buy	730,000 +45,000	+7%	+$552K	11.99%	1
2021 Q3	$8.95M	Sell	685,000 -835,000	-55%	-$10.8M	13.4%	1
2021 Q2	$19.6M	Buy	1,520,000 +70,000	+5%	+$801K	18.54%	1
2021 Q1	$16.2M	Buy	1,450,000 +615,000	+74%	+$6.5M	12.91%	1
2020 Q4	$9.51M	Buy	+835,000	New	+$9.14M	6.3%	6

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HealthInvest Partners's IRWD Position: Q2 2022 in Review

HealthInvest Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 710,000 shares — an estimated $8.93M sold.

HealthInvest Partners first reported a position in IRWD in Q4 2020 and held it in 6 quarters. The position peaked at $19.6M in Q2 2021. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

HealthInvest Partners reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
HealthInvest Partners sold 710,000 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $8.93M.
HealthInvest Partners first reported a position in Ironwood Pharmaceuticals in Q4 2020 and held it in 6 quarters.
HealthInvest Partners's Ironwood Pharmaceuticals position peaked at $19.6M in Q2 2021.
239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on HealthInvest Partners's 13F filing for Q2 2022, filed 8 Jul 2022.